IDEX (IEX) said its full year 2026 organic sales are projected to increase 1% to 2% over the prior year. Full year adjusted EPS is expected in a range of $8.15 to $8.35. For the first quarter, the company expects organic sales to increase approximately 1%, and adjusted EPS in a range of $1.73 to $1.78.
For the fourth quarter, the company's bottom line totaled $128.3 million, or $1.71 per share. This compares with $123.2 million, or $1.62 per share, last year. Excluding items, IDEX reported adjusted earnings of $157.2 million or $2.10 per share for the period. Revenue rose 4.2% to $899.1 million from $862.9 million last year.
In pre-market trading on NYSE, IDEX shares are down 0.3 percent to $201.00.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.